Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tino F Schwarz

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Expert Review of Vaccines|December 5, 2008
AS04-adjuvanted human papillomavirus-16/18 vaccination: recent advances in cervical cancer preventionTino F Schwarz
Advances in Therapy|December 22, 2009
Clinical update of the AS04-adjuvanted human papillomavirus-16/18 cervical cancer vaccine, CervarixTino F Schwarz
Gynecologic Oncology|July 26, 2008
Immune response to human papillomavirus after prophylactic vaccination with AS04-adjuvanted HPV-16/18 vaccine: improving upon natureTino F Schwarz, Oberdan Leo
Vaccine|November 6, 2012
Assessment of functional antibacterial opsonophagocytic antibodies elicited by 13-valent pneumococcal conjugate vaccine administered concomitantly with trivalent influenza vaccine in a randomized clinical trial in adults aged ≥65 yearsTino F Schwarz, Beate Schmoele-Thoma
Medizinische Klinik (Munich, Germany : 1983)|July 20, 2007
[Impact of vaccination against oncogenic human papillomavirus on the incidence and mortality of cervical cancer in Germany]Achim Schneider, Tino F Schwarz, Thomas Hammerschmidt, et al.
Virology Journal|April 27, 2005
Intracellular localization of Crimean-Congo Hemorrhagic Fever (CCHF) virus glycoproteinsSebastian Haferkamp, Lisa Fernando, Tino F Schwarz, et al.
International Journal of Medical Microbiology : IJMM|May 19, 2004
TBE booster immunization in adults--first experience with a new tick-borne encephalitis (TBE) vaccine, free of protein-derived stabilizerOlaf Zent, Tino F Schwarz, Annelie Plentz, et al.
Vaccine|April 18, 2015
Immunogenicity and reactogenicity of a decennial booster dose of a combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and inactivated poliovirus booster vaccine (dTpa-IPV) in healthy adultsMartina Kovac, Niraj Rathi, Sherine Kuriyakose, et al.
Expert Review of Vaccines|May 19, 2025
Virus-like particles: a versatile and effective vaccine platformMartin F Bachmann, Pierre van Damme, Florian Lienert, et al.
Vaccine|December 17, 2008
Long-term persistence of tick-borne encephalitis antibodies in adults 5 years after booster vaccination with Encepur AdultsAnnelie Plentz, Wolfgang Jilg, Tino F Schwarz, et al.
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Expert Review of Vaccines|December 5, 2008
AS04-adjuvanted human papillomavirus-16/18 vaccination: recent advances in cervical cancer preventionTino F Schwarz
Advances in Therapy|December 22, 2009
Clinical update of the AS04-adjuvanted human papillomavirus-16/18 cervical cancer vaccine, CervarixTino F Schwarz
Gynecologic Oncology|July 26, 2008
Immune response to human papillomavirus after prophylactic vaccination with AS04-adjuvanted HPV-16/18 vaccine: improving upon natureTino F Schwarz, Oberdan Leo
Vaccine|November 6, 2012
Assessment of functional antibacterial opsonophagocytic antibodies elicited by 13-valent pneumococcal conjugate vaccine administered concomitantly with trivalent influenza vaccine in a randomized clinical trial in adults aged ≥65 yearsTino F Schwarz, Beate Schmoele-Thoma
Medizinische Klinik (Munich, Germany : 1983)|July 20, 2007
[Impact of vaccination against oncogenic human papillomavirus on the incidence and mortality of cervical cancer in Germany]Achim Schneider, Tino F Schwarz, Thomas Hammerschmidt, et al.
Virology Journal|April 27, 2005
Intracellular localization of Crimean-Congo Hemorrhagic Fever (CCHF) virus glycoproteinsSebastian Haferkamp, Lisa Fernando, Tino F Schwarz, et al.
International Journal of Medical Microbiology : IJMM|May 19, 2004
TBE booster immunization in adults--first experience with a new tick-borne encephalitis (TBE) vaccine, free of protein-derived stabilizerOlaf Zent, Tino F Schwarz, Annelie Plentz, et al.
Vaccine|April 18, 2015
Immunogenicity and reactogenicity of a decennial booster dose of a combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and inactivated poliovirus booster vaccine (dTpa-IPV) in healthy adultsMartina Kovac, Niraj Rathi, Sherine Kuriyakose, et al.
Expert Review of Vaccines|May 19, 2025
Virus-like particles: a versatile and effective vaccine platformMartin F Bachmann, Pierre van Damme, Florian Lienert, et al.
Vaccine|December 17, 2008
Long-term persistence of tick-borne encephalitis antibodies in adults 5 years after booster vaccination with Encepur AdultsAnnelie Plentz, Wolfgang Jilg, Tino F Schwarz, et al.
Pageof 8